Case Report

J Rheum Dis 2017; 24(5): 309-312

Published online October 31, 2017

© Korean College of Rheumatology

Acquired Hemophilia A Combined with Systemic Lupus Erythematosus: A Case Report and Literature Review

Juyoung You1, Hojae Kim1, Jin Su Park2, Myung Hee Chang2, Chan Hee Lee2

1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, 2Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea

Correspondence to : Chan Hee Lee, Division of Rheumatology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, 100 Ilsan-ro, Ilsandong-gu, Goyang 10444, Korea. E-mail:chanheell@daum.net

Received: March 6, 2017; Revised: April 19, 2017; Accepted: April 21, 2017

This is a Open Access article, which permits unrestricted non-commerical use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Acquired hemophilia A (AHA) is a rare hemorrhagic disorder caused by autoantibodies against factor VIII (FVIII). An 80-year-old woman presented multiple bruises on her upper and lower extremities, along with gross hematuria. Extensive ecchymosis and swelling were observed on the buttocks. She had anemia and normal platelet count. The initial coagulation results showed prolonged activated partial thromboplastin time (aPTT, 68.5 seconds) and normal prothrombin time. According to the mixing test, we observed a decreased FVIII activity (2%), increased factor VIII inhibitor (FVIII-I) titer (74.4 BU), and negative lupus anticoagulant. AHA was diagnosed based on late onset bleeding and increased FVIII-I titer. Additionally, she met the criteria for systemic lupus erythematosus (oral ulcer, photosensitivity, renal disorder, and positivity for antinuclear and anti-β2-glycoprotein- I antibodies). She was started on oral prednisolone for FVIII-I eradication. Post-treatment, her bleeding tendency, aPTT (47.3 seconds), and FVIII-I titer decreased (1.24 BU), and FVIII activity increased (10%).

Keywords Hemophilia A, Acquired, Systemic lupus erythematosus

Article

Case Report

J Rheum Dis 2017; 24(5): 309-312

Published online October 31, 2017 https://doi.org/10.4078/jrd.2017.24.5.309

Copyright © Korean College of Rheumatology.

Acquired Hemophilia A Combined with Systemic Lupus Erythematosus: A Case Report and Literature Review

Juyoung You1, Hojae Kim1, Jin Su Park2, Myung Hee Chang2, Chan Hee Lee2

1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, 2Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea

Correspondence to:Chan Hee Lee, Division of Rheumatology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, 100 Ilsan-ro, Ilsandong-gu, Goyang 10444, Korea. E-mail:chanheell@daum.net

Received: March 6, 2017; Revised: April 19, 2017; Accepted: April 21, 2017

This is a Open Access article, which permits unrestricted non-commerical use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Acquired hemophilia A (AHA) is a rare hemorrhagic disorder caused by autoantibodies against factor VIII (FVIII). An 80-year-old woman presented multiple bruises on her upper and lower extremities, along with gross hematuria. Extensive ecchymosis and swelling were observed on the buttocks. She had anemia and normal platelet count. The initial coagulation results showed prolonged activated partial thromboplastin time (aPTT, 68.5 seconds) and normal prothrombin time. According to the mixing test, we observed a decreased FVIII activity (2%), increased factor VIII inhibitor (FVIII-I) titer (74.4 BU), and negative lupus anticoagulant. AHA was diagnosed based on late onset bleeding and increased FVIII-I titer. Additionally, she met the criteria for systemic lupus erythematosus (oral ulcer, photosensitivity, renal disorder, and positivity for antinuclear and anti-β2-glycoprotein- I antibodies). She was started on oral prednisolone for FVIII-I eradication. Post-treatment, her bleeding tendency, aPTT (47.3 seconds), and FVIII-I titer decreased (1.24 BU), and FVIII activity increased (10%).

Keywords: Hemophilia A, Acquired, Systemic lupus erythematosus

JRD
Jan 01, 2025 Vol.32 No.1, pp. 1~7
COVER PICTURE
Cumulative growth of rheumatology members and specialists (1980~2024). Cumulative distribution of the number of the (A) Korean College of Rheumatology members and (B) rheumatology specialists. (J Rheum Dis 2025;32:63-65)

Stats or Metrics

Share this article on

  • line

Related articles in JRD

Journal of Rheumatic Diseases

pISSN 2093-940X
eISSN 2233-4718
qr-code Download